Skip to content

Clinical trials

Observational Hypertension trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Observational Country / region: Japan Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20092
20101
20112
20121
20142
20172
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda6
Boehringer Ingelheim4
Bayer1
Dokkyo Medical University1
Jichi Medical University1
Nagoya University1
Novartis Pharmaceuticals1
Osaka Metropolitan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension16
Diabetes Mellitus3
Diabetes Mellitus, Type 22
Dyslipidemias2
Hyperlipidemias2
Insulin Resistance2
Metabolic Syndrome2
Renal Insufficiency, Chronic2
Atherosclerosis1
Diabetic Nephropathies1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.